Prostate Cancer Canada
Toronto, ON M5C 1M1
President & CEO: Rocco Rossi
Board Chair: Ted Nash
Charitable Reg. #: 89127 0944 RR0001
Social Results Reporting
Grade: A-The grade is based on the charity's public reporting of the work it does and the results it achieves.
Program Cost Coverage
Full-time staff #40
Avg. Compensation $86,557
Top 10 Staff Salary Range
|$300k - $350k||0|
|$250k - $300k||0|
|$200k - $250k||1|
|$160k - $200k||0|
|$120k - $160k||2|
|$80k - $120k||6|
|$40k - $80k||0|
About Prostate Cancer Canada:
Founded in 1994, Prostate Cancer Canada (PCC) funds research projects looking to improve diagnostic tests and develop improved treatments for prostate cancer. PCC also provides support services to improve the lives of patients and survivors of the disease. Prostate cancer is the most common cancer in men, accounting for approximately 24% of all new cancer cases in men. One in every eight Canadian men will have the disease at some point in their life.
Prostate Cancer Canada's research programs accounted for $18.6m of the charity's spending in 2015. PCC provides grants to fund projects that look into one of six major categories of prostate cancer research: biology of the disease; causes of the disease; prevention of the disease; early detection and prognosis of the disease; treatment for patients; and control, survivorship and outcomes. PCC provided 47 new grants to propel prostate cancer research in 2015, bringing the total number of PCC-funded projects to 120. In 2015, 66 scientific papers were published by research groups funded by PCC grant money.
Prostate Cancer Canada has an established partnership with the Movember Foundation. PCC receives funds raised by Movember and determines research groups and projects deserving of grants and awards. In 2015, Movember provided PCC with $10.7m for granting purposes, in F2014 $14.5m, and in F2013 $32.9m.
As a part of its support services programming, PCC introduced the True NTH program in 2015. The program is designed to help prostate cancer patients get better access to information and services to improve their quality of life. Funding for the program comes from the Movember Foundation. True NTH connects patients with physicians, experts, survivors, caregivers, and key leaders in the field of prostate cancer research and treatment. It runs in six countries across the world and provides services related to lifestyle management, decision support aid, palliative care and peer-to-peer support.
Prostate Cancer Canada is one of Canada's 100 largest charities in terms of donations. In F2015, the charity collected $18.4m in donations and special events revenues. Administrative costs are 7% of revenues and fundraising costs are 43% of donations. Combined, PCC spends $0.50 of every donated dollar on overhead costs, which exceeds Ci's reasonable range for overhead spending. Funds received from Movember Canada were not included when calculating the charity's fundraising cost ratio.
Prostate Cancer Canada has funding reserves of $27.4m ($12.1m of which are "donor-endowed" by Movember Canada). Prostate Cancer Canada has committed to grant $20.4m in the next year and has additional long-term grant commitments for future years of $23.8m. Current funding reserves cover annual program costs for 1.3 years. Factoring in Prostate Cancer Canada's grant commitments there is a funding need for donations.
This report is an update that is currently being reviewed by PCC. Changes and edits may be forthcoming.
Updated on June 3, 2016 by Katie Khodawandi.
Financial RatiosFiscal year ending March
|Administrative costs as % of revenues||6.8%||5.6%||5.0%|
|Fundraising costs as % of donations||42.9%||39.4%||49.6%|
|Program cost coverage (%)||130.6%||284.2%||389.6%|
Summary Financial StatementsAll figures in $000s
|Cash flow from operations||(6,381)||6,009||27,610|